Reuters UK Business

France’s Saint-Gobain posts record revenue, beats estimates

By Dina Kartit (REUTERS) – French construction materials giant Compagnie de Saint-Gobain on Thursday posted record annual revenue that exceeded analysts’ expectations on strong growth in all its regions and despite higher inflation and concerns over economic growth. Revenue was 51.2 billion euros ($54.15 billion), up 15.9% from 2021. A Refinitiv consensus drawn from 21 …

France’s Saint-Gobain posts record revenue, beats estimates Read More »

Germany would have no problem with a Europe-wide Russian gas ban, minister Habeck says

BERLIN (Reuters) – Germany would be fine with a Europe-wide ban on Russian gas, but other countries would not, meaning it was better to focus on sealing gaps in the sanctions regime rather than expanding it, Economy Minister Robert Habeck said. Germany companies were no longer using any Russian gas, he said. “So as far …

Germany would have no problem with a Europe-wide Russian gas ban, minister Habeck says Read More »

Britain’s salad crisis could last another month

By James Davey LONDON (Reuters) – Britons may face shortages of salad staples, including tomatoes, cucumbers and peppers, for up to another month, the government said on Thursday. On Wednesday, Britain’s biggest supermarket group Tesco followed rivals Asda, Morrisons and Aldi in imposing customer purchase limits on salad items after supplies were hit by disrupted …

Britain’s salad crisis could last another month Read More »

FTSE 100 slips as ex-dividend trades weigh, Rolls-Royce soars

By Shashwat Chauhan and Shristi Achar A (Reuters) -The FTSE 100 ended lower on Thursday, as several banking and healthcare heavyweights traded ex-dividend, although shares of Rolls-Royce zoomed more than 20% after the aeroplane engine maker reported upbeat results. The blue-chip index was down 0.3%, declining for a third straight session. Shares of banks including …

FTSE 100 slips as ex-dividend trades weigh, Rolls-Royce soars Read More »

Biotech firms Redx Pharma and Jounce Therapeutics to merge in $425 million deal

(Reuters) -British biotech firm Redx Pharma plc and U.S.-based Jounce Therapeutics Inc will merge to create a $425 million entity specialised in treating cancer and fibrotic disease. Redx shareholders will receive 0.2105 Jounce share in exchange for each Redx share, the companies said on Thursday, adding that the combined company would be called Redx Inc …

Biotech firms Redx Pharma and Jounce Therapeutics to merge in $425 million deal Read More »

Telefonica hits earnings targets, forecasts steady growth for 2023

MADRID (Reuters) – Spain’s Telefonica forecast steady revenue and earnings growth for 2023 to send the telecom firm’s shares higher on Thursday after posting on-target numbers for last year. Telefonica said it expected its overall revenue including its British joint-venture and excluding currency swings and M&A effects, to rise at “a low single digit rate” …

Telefonica hits earnings targets, forecasts steady growth for 2023 Read More »

Italy’s Eni posts record profit but markets unimpressed

By Francesca Landini MILAN (Reuters) -Italian energy group Eni said on Thursday its adjusted net profit rose to 13.3 billion euros ($14.12 billion) in 2022, the largest in over a decade, but its shares fell as markets focused on a weaker exploration and production performance in Q4. The state-controlled group’s 2022 performance was boosted by …

Italy’s Eni posts record profit but markets unimpressed Read More »

Close Bitnami banner
Bitnami